NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 71 filers reported holding NOVELION THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 831,440 | $8,930,000 | 15.27% |
| Stonepine Capital Management, LLC | 1,560,487 | $16,760,000 | 9.44% |
| Sarissa Capital Management LP | 1,025,000 | $11,008,000 | 4.35% |
| ARMISTICE CAPITAL, LLC | 1,852,000 | $19,890,000 | 4.11% |
| Opaleye Management Inc. | 730,000 | $7,840,000 | 3.90% |
| Broadfin Capital, LLC | 1,948,554 | $20,927,000 | 2.54% |
| Tiger Legatus Capital Management, LLC | 447,852 | $4,810,000 | 2.10% |
| JW Asset Management, LLC | 310,299 | $3,333,000 | 0.69% |
| Kingstown Capital | 599,998 | $6,444,000 | 0.67% |
| KNOTT DAVID M | 109,184 | $1,173,000 | 0.56% |